ENDO INTERNATIONAL PLC news, videos and press releases
For more news please use our advanced search feature.
ENDO INTERNATIONAL PLC - More news...
ENDO INTERNATIONAL PLC - More news...
- Endo, Inc. Completes Acquisition of Endo International plc's Assets
- Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
- Endo, Inc. Announces Pricing of $1.5 billion of Senior Secured Term Loan as Part of Endo's $2.5 billion Exit Financing
- Endo, Inc. Announces Pricing of $1.0 billion of Senior Secured Notes
- Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
- Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
- Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
- Endo Announces Confirmation of Plan of Reorganization
- Endo Announces Confirmation of Plan of Reorganization
- Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
- ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
- ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
- Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
- Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
- Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
- Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
- Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting
- ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION
- ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION
- Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
- Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
- ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
- ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
- Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
- Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
- ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
- ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
- Endo Announces First Patient Enrolled in Registry of Peyronie's Disease
- Endo Launches Bivalirudin Injection in Ready-to-Use Vials
- Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage
